Gopi Shah Goda

Senior Research Scholar and Postdoctoral Fellow Program Coordinator, Stanford Institute for Economic Policy Research (SIEPR) Research interests: Public Finance, Health Economics, Applied Microeconomics,Labor Economics, Economic Demography, Actuarial Science Email: gopi@stanford.edu Phone: (650) 736-0480 Address: Stanford Institute for Economic Policy Research (SIEPR) Stanford University 366 Galvez Street Stanford, CA 94305-6015  Website: http://www.stanford.edu/~gopi/index.html  

Hazel Markus

Davis-Brack Professor in the Behavioral Sciences Research interests: Sociocultural shaping of mind and self; how gender, ethnicity, religion, social class, cohort, or region or country of national origin may influence thought and feeling, particularly self-relevant thought and feeling; similarities and differences in the nature of self-concept and in the functioning of self-esteem; age and cohort variation… Read more Hazel Markus

Marcia Stefanick

Professor (Research) of Medicine (Stanford Prevention Research Center) and of Obstetrics and Gynecology Research interests: Chronic disease prevention (particularly, heart disease, breast cancer, osteoporosis, and dementia) in both women and men; the effects of menopausal hormones on cardiovascular and other health outcomes in mostly healthy postmenopausal women (in the Womens Health Initiative, WHI), in women with established… Read more Marcia Stefanick

B.J. Fogg

Director, Persuasive Technology Lab Research interests: Creating insight into how computing products–from websites to mobile phone software–can be designed to change people’s beliefs and behaviors; technology for creating health habits; mobile persuasion; the psychology of Facebook Department: Persuasive Technology Lab Email: bjfogg@stanford.edu Address: P.O. Box 20456 Stanford University, Stanford, CA 94305 Website: http://www.bjfogg.com

10/27/2012 - What Medicare Will Cover Even if You’re Not Likely to Get Better

Should the federal government cover the costs of many kinds of treatments for patients who aren’t going to get any better? It didn’t, for many years. But after the settlement of a landmark class-action lawsuit this week, Medicare will soon begin paying more often for physical, occupational and other therapies for large numbers of people… Read more 10/27/2012 - What Medicare Will Cover Even if You’re Not Likely to Get Better

10/25/2012 - More Americans Delaying Retirement Until Age 80

As they struggle to save for retirement, a growing number of middle-class Americans plan to postpone their golden years until they are in their 80’s. Nearly one-third, or 30%, now plan to work until they are 80 or older — up from 25% a year ago, according to a Wells Fargo survey of 1,000 adults… Read more 10/25/2012 - More Americans Delaying Retirement Until Age 80

10/24/2012 - U.S. elderly, middle-aged see higher obesity rates: poll

Data from nearly 600,000 U.S. adults showed that people aged 18 and older were more likely to be obese than they were in 2008, according to the Gallup survey. Researchers noted a significant jump among adults in their 40s, 70s and 80s. Read the full article at Reuters.

10/24/2012 - Many in Middle Class ‘Guess’ on Retirement Needs

Three-fourths of middle-class Americans say their estimate of what they’ll need to live on in retirement is based on “some sort of guess,” a new survey finds. And those guesses often appear off the mark, according to the annual Wells Fargo Retirement Survey. Read the full article at The New York Times.

10/24/2012 - The Island Where People Forget to Die

In 1943, a Greek war veteran named Stamatis Moraitis came to the United States for treatment of a combat-mangled arm. He’d survived a gunshot wound, escaped to Turkey and eventually talked his way onto the Queen Elizabeth, then serving as a troopship, to cross the Atlantic. Moraitis settled in Port Jefferson, N.Y., an enclave of… Read more 10/24/2012 - The Island Where People Forget to Die

10/19/2012 - Alzheimer’s Prevention Seen Promising as Drug Cures Fail

Three studies set to explore the use of experimental drugs that may become the first to change the course of Alzheimer’s disease aren’t looking to cure the illness. Their goal is to prevent it altogether. Read the full article at the San Francisco Chronicle.